ArticlePharmaceuticals (Basel, Switzerland)2021

Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies.

Jiawang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.